13F-HR filed by Eagle Health Investments LP
Eagle Health Investments LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-10, with 28 holding rows worth $410,447,000.
- Accession
- 0001842545-22-000003
- Filer
- CIK 1842545
- Filed
- 2022-02-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 28 entries on the cover page, a total value of $410,447,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $410,447,000 with VALUE read as thousands by filing date, 13F file number 028-20556. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HUMANA INC COM | 444859102 | Stock | 78,621 | $36,469,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 611,665 | $35,629,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 153,438 | $33,155,000 | thousands by filing date | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 99,577 | $28,095,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 62,332 | $21,828,000 | thousands by filing date | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 750,760 | $21,066,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 192,639 | $20,634,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 211,694 | $19,770,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 113,702 | $19,282,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 82,144 | $18,039,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 76,253 | $17,543,000 | thousands by filing date | |
| CANO HEALTH INC | 13781Y103 | COM | 1,947,779 | $17,355,000 | thousands by filing date | |
| OUTSET MEDICAL INC | 690145107 | COM | 329,000 | $15,164,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 256,465 | $14,362,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 26,700 | $14,337,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 431,413 | $14,181,000 | thousands by filing date | |
| AMERICAN WELL CORP | 03044L105 | CL A | 2,247,908 | $13,577,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 80,500 | $12,445,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 119,360 | $11,938,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 52,000 | $7,628,000 | thousands by filing date | |
| CAREMAX INC | 14171W103 | COM | 714,755 | $5,489,000 | thousands by filing date | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 132,090 | $2,898,000 | thousands by filing date | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 37,000 | $2,349,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 28,900 | $2,303,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 23,000 | $1,889,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 47,200 | $1,520,000 | thousands by filing date | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 100,000 | $774,000 | thousands by filing date | |
| OLINK HLDG AB | 680710100 | ADR | 40,000 | $728,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001842545-22-000003 | this filing | 2022-02-10 | acceptance time not in the bulk data set |